Risks and Unknowns Remaining research gaps include: Long-term systemic administration data Optimal dosing strategies outside dermatology Interaction with copper metabolism disorders Comparative efficacy versus standard wound treatments Most evidence supports local, tissue specific effects rather than systemic transformation
Guo L, Peng Y, Yao J, Sui L, Gu A, Wang J
It assists the immune system in functioning
CJC-1295 has been shown in human studies to increase GH and insulin-like growth factor 1 (IGF-1) levels (Teichman et al., 2006)
G/D-CuP was engineered to exert therapeutic effects across all phases of wound repair while targeting diverse pathological mechanisms, hence in vitro effects were validated
Like a nutritional insurance plan, a good daily supplement can help fill in the gaps